Update in Molecular Diagnostics in Melanocytic Neoplasms

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Advances in Anatomic Pathology

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/PAP.0b013e318271a5cbPMID 23060066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The genetics of uveal melanoma: an emerging framework for targeted therapy

  2012cited by this paper
• Distinctive Clinical and Histologic Features in Cutaneous Melanoma With Copy Number Gains in 8q24

  2012cited by this paper
• A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms

  2012cited by this paper
• Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib.

  2012cited by this paper
• Enhanced Detection of Spitzoid Melanomas Using Fluorescence In Situ Hybridization With 9p21 as an Adjunctive Probe

  2012cited by this paper
• Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• Vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• Germline mutations in BAP1 predispose to melanocytic tumors

  2011cited by this paper
• Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

  2011cited by this paper
• Germline BAP1 mutations predispose to malignant mesothelioma

  2011cited by this paper
• Copy Number Variations and Clinical Outcome in Atypical Spitz Tumors

  2011cited by this paper
• Melanocytic Nevi With An Atypical Epithelioid Cell Component: Clinical, Histopathologic, and Fluorescence In Situ Hybridization Findings

  2011cited by this paper
• Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma.

  2011cited by this paper
• Long-term outcome of Spitz-type melanocytic tumors.

  2011cited by this paper
• Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

  2011cited by this paper
• Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis.

  2011cited by this paper
• Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi

  2011cited by this paper
• Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus‐like melanoma

  2011cited by this paper
• Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases

  2011cited by this paper
• RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF

  2010cited by this paper
• Immunohistochemical evaluation of p16INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors.

  2010cited by this paper
• Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up

  2010cited by this paper
• The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study

  2010cited by this paper
• RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

  2010cited by this paper
• Mutations in GNA11 in uveal melanoma.

  2010cited by this paper
• BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.

  2009cited by this paper
• Distinguishing Epithelioid Blue Nevus From Blue Nevus-like Cutaneous Melanoma Metastasis Using Fluorescence In Situ Hybridization

  2009cited by this paper
• The atypical Spitz tumor of uncertain biologic potential

  2009cited by this paper
• The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1*

  2009cited by this paper
• Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi

  2009cited by this paper
• The superficial atypical Spitz tumor and malignant melanoma of superficial spreading type arising in association with the superficial atypical Spitz tumor: A distinct form of dysplastic Spitzoid nevomelanocytic proliferation.

  2009cited by this paper
• p16 Expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma

  2009cited by this paper
• Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

  2009cited by this paper
• Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi

  2008cited by this paper
• BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.

  2008cited by this paper
• Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis

  2005cited by this paper
• Effects of G-protein mutations on skin color

  2004cited by this paper
• Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF‐1

  2003cited by this paper
• Classifying melanocytic tumors based on DNA copy number changes.

  2003cited by this paper
• G Protein Pathways

  2002cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

  2000cited by this paper
• Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.

  1999cited by this paper
• BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

  1998cited by this paper
• Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

  1998cited by this paper
• Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.

  1996cited by this paper
• GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4.

  1995cited by this paper
• Immunophenotyping of compound and spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections.

  1993cited by this paper
• Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells

  1992cited by this paper
• GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours

  1989cited by this paper

• New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells

  2022cites this paper
• Common and not so Common Melanocytic Lesions in Children and Adolescents

  2018cites this paper
• Giant Conjunctival Melanoma with Breast Cancer and Chronic Lymphocytic Leukemia: A Case Report and Mini-Review of the Literature

  2017cites this paper
• Classification of melanocytic nevi

  2017cites this paper
• Nanomedicine in Melanoma: Current Trends and Future Perspectives

  2017cites this paper
• Atypical pterygium revealing a conjunctival melanoma

  2016cites this paper
• Molecular testing in Cutaneous Melanoma

  2014cites this paper
• Management of conjunctival malignant melanoma: a review and update

  2014cites this paper
• Keeping up with the times: revising the dermatology residency curriculum in the era of molecular diagnostics and personalized medicine

  2014cites this paper
• Controversial tumors in pediatric surgical oncology.

  2014cites this paper
• Comparative genomic hybridization in a case of melanoma that loses expression of S100, HMB45, Melan A and tyrosinase in metastasis.

  2014influential citation
• Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients

  2014cites this paper
• Fluorescence In Situ Hybridization Analysis of Atypical Melanocytic Proliferations and Melanoma in Young Patients

  2014cites this paper
• Molecular testing in the diagnosis of melanocytic tumors

  2013cites this paper
• GENOME-WIDE PROFILING OF COPY NUMBER ALTERATIONS IN CANCER: FOCUS ON MELANOMA

  2013cites this paper
• Characteristics and side effects of common nanoparticles used in the study of melanoma treatment Nanoparticle

  2013cites this paper
• Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics

  2013cites this paper